BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND MAP2K1, MAPKK1, 5604, ENSG00000169032, Q02750, MEK1, MKK1, PRKMK1
27 results:

  • 1. AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
    Gan Q; Huang X; Zhao W; Liu H; Xu Y; Zhang X; Cheng J; Chen R
    BMC Cancer; 2023 Apr; 23(1):364. PubMed ID: 37081411
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. An in vitro carcinogenesis model for cervical cancer harboring episomal form of HPV16.
    Wongjampa W; Nakahara T; Tanaka K; Yugawa T; Ekalaksananan T; Kleebkaow P; Goshima N; Kiyono T; Pientong C
    PLoS One; 2023; 18(2):e0281069. PubMed ID: 36763589
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. SEC61G Promotes cervical cancer Proliferation by Activating MAPK Signaling Pathway.
    Fan Y; Wang Y; Liu F; Wang H; Li Q
    Dis Markers; 2022; 2022():7016079. PubMed ID: 36092956
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cobimetinib Sensitizes cervical cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation.
    Liu Y; Zhao R; Qin X; Mao X; Li Q; Fang S
    Pharmacology; 2022; 107(7-8):398-405. PubMed ID: 35526525
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications.
    Gomes FG; Almeida VH; Martins-Cardoso K; Martins-Dinis MMDC; Rondon AMR; Melo AC; Tilli TM; Monteiro RQ
    Braz J Med Biol Res; 2021; 54(6):e10754. PubMed ID: 33886813
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma.
    Song TT; Xu F; Wang W
    Kaohsiung J Med Sci; 2020 Jul; 36(7):501-507. PubMed ID: 32196955
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. RCE‑4, a potential anti‑cervical cancer drug isolated from Reineckia carnea, induces autophagy via the dual blockade of PI3K and ERK pathways in cervical cancer CaSki cells.
    Xiang W; Zhang RJ; Jin GL; Tian L; Cheng F; Wang JZ; Xing XF; Xi W; Tang SJ; Chen JF
    Int J Mol Med; 2020 Jan; 45(1):245-254. PubMed ID: 31746346
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
    Che Y; Li Y; Zheng F; Zou K; Li Z; Chen M; Hu S; Tian C; Yu W; Guo W; Luo M; Deng W; Zou L
    Cancer Lett; 2019 Jun; 452():1-13. PubMed ID: 30905820
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Praeruptorin A Inhibits Human cervical cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling.
    Wu MH; Lin CL; Chiou HL; Yang SF; Lin CY; Liu CJ; Hsieh YH
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267213
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1.
    Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
    J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NF-κB-induced KIAA1199 promotes survival through EGFR signalling.
    Shostak K; Zhang X; Hubert P; Göktuna SI; Jiang Z; Klevernic I; Hildebrand J; Roncarati P; Hennuy B; Ladang A; Somja J; Gothot A; Close P; Delvenne P; Chariot A
    Nat Commun; 2014 Nov; 5():5232. PubMed ID: 25366117
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Identification of novel inhibitors of human Chk1 using pharmacophore-based virtual screening and their evaluation as potential anti-cancer agents.
    Kumar V; Khan S; Gupta P; Rastogi N; Mishra DP; Ahmed S; Siddiqi MI
    J Comput Aided Mol Des; 2014 Dec; 28(12):1247-56. PubMed ID: 25312395
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A critical role of MYC for transformation of human cells by HPV16 E6E7 and oncogenic HRAS.
    Narisawa-Saito M; Inagawa Y; Yoshimatsu Y; Haga K; Tanaka K; Egawa N; Ohno S; Ichikawa H; Yugawa T; Fujita M; Kiyono T
    Carcinogenesis; 2012 Apr; 33(4):910-7. PubMed ID: 22345164
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway.
    Ying TH; Yang SF; Tsai SJ; Hsieh SC; Huang YC; Bau DT; Hsieh YH
    Arch Toxicol; 2012 Feb; 86(2):263-73. PubMed ID: 21964635
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin.
    Wang X; Govind S; Sajankila SP; Mi L; Roy R; Chung FL
    Mol Nutr Food Res; 2011 Oct; 55(10):1572-81. PubMed ID: 21595016
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Treatment of a human papillomavirus type 31b-positive cell line with benzo[a]pyrene increases viral titer through activation of the Erk1/2 signaling pathway.
    Bowser BS; Alam S; Meyers C
    J Virol; 2011 May; 85(10):4982-92. PubMed ID: 21367897
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9.
    Mühlen S; Behren A; Iftner T; Simon C
    Int J Oncol; 2010 Aug; 37(2):337-45. PubMed ID: 20596661
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation.
    Rosenberger S; De-Castro Arce J; Langbein L; Steenbergen RD; Rösl F
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7006-11. PubMed ID: 20351270
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Influce of lysophosphatidic acid on proliferation, adhesion, migration and apoptosis of cervical cancer HeLa cells].
    Sun H; Zhu Q; Ren J; Wu L; Kong FZ; Li G; Hu HF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):702-5. PubMed ID: 19664393
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells.
    Meira DD; de Almeida VH; Mororó JS; Nóbrega I; Bardella L; Silva RL; Albano RM; Ferreira CG
    Br J Cancer; 2009 Sep; 101(5):782-91. PubMed ID: 19654571
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.